Embark Group AB (”Embark” eller ”Bolaget”) släppte en stark rapport för det tredje kvartalet där int...
Analyst Group inleder analysbevakning på Neovici, vilket innefattar analysbevakning med bland annat ...
Redeye comments on MindArk’s Q3 results, which were weaker than expected in both sales and profitabi...
Redeye provides a more in-depth review of AcouSort’s Q3 report, which did not include any major supr...
CMD: Solid M&A runway, improved underlying profitability Increased confidence in 15% growth potentia...
Zoomability Int AB (”Zoomability” eller ”bolaget”) meddelade den 27 november att bolaget har testat ...
STENOCARE announced on November 26th the STENOCARE 3.
Fortsatt svag konsumentmarknad Omsättningen i det tredje kvartalet minskade med 13,3 procent, vilket...
Redeye comments on FluoGuide’s Q3 2024 report, following its recent business update on FG001’s plann...
Redeye shares its initial take on TH1NG’s Q3 report, in which revenues were in line with our modest ...
Redeye briefly comments on the positive news that Saniona has outlicensed SAN711 to Acadia in neurol...
Educational day with presentations from core holdings DP Patterning: small initial investment, large...
Redeye shares its key takeaways and nuggets from Devyser’s Capital Markets Day.
De diskussioner som Eastnine bekräftade i början av november har idag mynnat ut i ett jätteförvärv a...
Vaxxa är ett e-handelsbolag som driver en digital auktionstjänst, där bolaget syftar till att erbjud...
